Literature DB >> 20674748

Expression and purification of 15 kDa granulysin utilizing an insect cell secretion system.

Michael W Finn1, Carol Clayberger, Alan M Krensky.   

Abstract

Granulysin is an antimicrobial and proinflammatory protein expressed in activated human T cells and natural killer cells. A single mRNA produces the 15 kDa isoform which is then cleaved at the amino and carboxy termini to produce the 9 kDa isoform. Recombinant 9 kDa granulysin has been studied in detail but little is known about the function of the 15 kDa isoform, and no protocol has been published describing expression and purification of this form. Two commercially available preparations of the recombinant 15 kDa granulysin contain tags that may affect function. Here we describe for the first time a method to produce 15 kDa granulysin as a secreted protein from insect cells. The 15 kDa granulysin is purified using a HiTrap Heparin column and a Resource S column. A typical a yield of purified 15 kDa granulysin is 0.6 mg/L of insect cell supernatant. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20674748      PMCID: PMC2966544          DOI: 10.1016/j.pep.2010.07.009

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  19 in total

1.  Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  Wen-Hung Chung; Shuen-Iu Hung; Jui-Yung Yang; Shih-Chi Su; Shien-Ping Huang; Chun-Yu Wei; See-Wen Chin; Chien-Chun Chiou; Sung-Chao Chu; Hsin-Chun Ho; Chih-Hsun Yang; Chi-Fang Lu; Jer-Yuarn Wu; You-Di Liao; Yuan-Tsong Chen
Journal:  Nat Med       Date:  2008-11-23       Impact factor: 53.440

Review 2.  Novel strategies for improved cancer vaccines.

Authors:  Xiaochuan Chen; Chien-Hsing Chang; David M Goldenberg
Journal:  Expert Rev Vaccines       Date:  2009-05       Impact factor: 5.217

3.  A human T cell-specific molecule is a member of a new gene family.

Authors:  T J Schall; J Jongstra; B J Dyer; J Jorgensen; C Clayberger; M M Davis; A M Krensky
Journal:  J Immunol       Date:  1988-08-01       Impact factor: 5.422

Review 4.  Granulysin.

Authors:  Carol Clayberger; Alan M Krensky
Journal:  Curr Opin Immunol       Date:  2003-10       Impact factor: 7.486

5.  Granulysin, a T cell product, kills bacteria by altering membrane permeability.

Authors:  W A Ernst; S Thoma-Uszynski; R Teitelbaum; C Ko; D A Hanson; C Clayberger; A M Krensky; M Leippe; B R Bloom; T Ganz; R L Modlin
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

Review 6.  Granulysin: a novel antimicrobial.

Authors:  J Kumar; S Okada; C Clayberger; A M Krensky
Journal:  Expert Opin Investig Drugs       Date:  2001-02       Impact factor: 6.206

Review 7.  Taking dendritic cells into medicine.

Authors:  Ralph M Steinman; Jacques Banchereau
Journal:  Nature       Date:  2007-09-27       Impact factor: 49.962

Review 8.  An update on Stevens-Johnson syndrome and toxic epidermal necrolysis in children.

Authors:  Mark Jean-Aan Koh; Yong-Kwang Tay
Journal:  Curr Opin Pediatr       Date:  2009-08       Impact factor: 2.856

9.  Evaluation of 3 clinical dendritic cell maturation protocols containing lipopolysaccharide and interferon-gamma.

Authors:  Tae Hee Han; Ping Jin; Jiaqiang Ren; Stefanie Slezak; Francesco M Marincola; David F Stroncek
Journal:  J Immunother       Date:  2009-05       Impact factor: 4.456

10.  A cDNA clone expressed in natural killer and T cells that likely encodes a secreted protein.

Authors:  T Yabe; C McSherry; F H Bach; J P Houchins
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

View more
  5 in total

1.  Mutant GNLY is linked to Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  Dora Janeth Fonseca; Luz Adriana Caro; Diana Carolina Sierra-Díaz; Carlos Serrano-Reyes; Olga Londoño; Yohjana Carolina Suárez; Heidi Eliana Mateus; David Bolívar-Salazar; Ana Francisca Ramírez; Alejandra de-la-Torre; Paul Laissue
Journal:  Hum Genet       Date:  2019-10-14       Impact factor: 4.132

2.  15 kDa granulysin causes differentiation of monocytes to dendritic cells but lacks cytotoxic activity.

Authors:  Carol Clayberger; Michael W Finn; Tianhong Wang; Reena Saini; Christine Wilson; Valarie A Barr; Marianna Sabatino; Luciano Castiello; David Stroncek; Alan M Krensky
Journal:  J Immunol       Date:  2012-05-14       Impact factor: 5.422

3.  15 kDa Granulysin versus GM-CSF for monocytes differentiation: analogies and differences at the transcriptome level.

Authors:  Luciano Castiello; David F Stroncek; Michael W Finn; Ena Wang; Francesco M Marincola; Carol Clayberger; Alan M Krensky; Marianna Sabatino
Journal:  J Transl Med       Date:  2011-04-18       Impact factor: 5.531

4.  Antimicrobial Properties of an Immunomodulator - 15 kDa Human Granulysin.

Authors:  Hung-Mu Wei; Li-Chih Lin; Chiu-Feng Wang; Yi-Jang Lee; Yuan-Tsong Chen; You-Di Liao
Journal:  PLoS One       Date:  2016-06-08       Impact factor: 3.240

5.  Improved Purification of Human Granzyme A/B and Granulysin Using a Mammalian Expression System.

Authors:  Valerio Rasi; Owais Abdul Hameed; Patricia Matthey; Sibes Bera; Duane P Grandgenett; Stefan Salentinig; Michael Walch; Daniel F Hoft
Journal:  Front Immunol       Date:  2022-03-01       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.